Stereotaxis
Stereotaxis is a global leader in innovative surgical robotics for minimally invasive endovascular procedures, enhancing patient care with robotic precision and improving interventional laboratory efficiency.
Stereotaxis (NYSE: STXS) stands as a global leader and pioneer in the field of surgical robotics, specifically designed for minimally invasive endovascular intervention.
Dedicated to the discovery, development, and delivery of robotic systems, instruments, and information solutions, Stereotaxis enhances the interventional laboratory environment. The company's innovations empower physicians to deliver exceptional patient care with robotic precision and safety, broaden access to minimally invasive therapies, and improve operating room productivity, connectivity, and intelligence.
To date, Stereotaxis technology has been utilized in treating over 150,000 patients in the United States, Europe, Asia, and other regions worldwide.
